Bulk of 2025 renumeration came from share bonuses as drug company’s now former CEO benefitted from stock rise ...

An announcement from GlaxoSmithKline ( (GSK) ) is now available.

An update from GlaxoSmithKline ( (GSK) ) is now available.

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Citigroup raises BAE Systems price target to 2,438 (2,192) pence - 'buy' Barclays ...

The recent exodus of prominent female leaders from the FTSE 100 (Debra Crew at Diageo, Emma Walmsley at GSK and Liv Garfield ...

Erginbilgic, pictured, has led a stunning turnaround, and has been rewarded with a deal that puts him on course to rival ...

Harvey Jones is looking for the best stocks to buy over the next few weeks and wonders whether there's an opportunity in two recent FTSE 100 winners. The post Up 18% and 16% in February! Are these 2 ...

SCYNEXIS received a one-time non-refundable payment in Q4 2025 totalling $24.8 million from GSK SCYNEXIS announced dosing of the first patient ...

There has traditionally been a comforting certainty that healthcare companies provide ballast in a portfolio. It was long ...

Theravance Biopharma said it is chopping its workforce by 50% and launching a review of strategic alternatives designed to maximize shareholder value, after its sole rare disease pipeline candidate, ...

Retail investors will be able to subscribe to the IPO from March 5-10. Read more at straitstimes.com. Read more at ...

Conference Call Begins at 4:30 p.m. Eastern Time TodayEMERYVILLE, Calif.--(BUSINESS WIRE)--$OABI #OABI--OmniAb, Inc. (NASDAQ: ...